Evidence map›Paper›PMID 23807769›Full record

ArticleLeukemia2014

The clinical relevance of minor paroxysmal nocturnal hemoglobinuria clones in refractory cytopenia of childhood: a prospective study by EWOG-MDS.

A M Aalbers, V H J van der Velden, A Yoshimi, A Fischer, P Noellke, C M Zwaan, I Baumann, H B Beverloo, M Dworzak, H Hasle and 11 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Myelodysplastic and myeloproliferative disorders of childhood.Hematology. American Society of Hematology. Education Program · 2016
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 8 countries.

A M Aalbers1] Department of Pediatric Oncology/Hematology, Sophia Children's Hospital-Erasmus University Medical Center, Rotterdam, The Netherlands [2] Department of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
V H J van der VeldenDepartment of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
A YoshimiDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany.
A FischerDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany.
P NoellkeDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany.
C M ZwaanDepartment of Pediatric Oncology/Hematology, Sophia Children's Hospital-Erasmus University Medical Center, Rotterdam, The Netherlands.
I BaumannDepartment of Pathology, Clinical Centre South West, Böblingen Clinics, Böblingen, Germany.
H B BeverlooDepartment of Clinical Genetics, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
M DworzakSt. Anna Children's Hospital and Children's Cancer Research Institute, Department of Pediatrics, Medical University of Vienna, Vienna, Austria.
H HasleDepartment of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark.
F LocatelliDepartment of Pediatric Hematology-Oncology, IRCCS Ospedale Bambino Gesù, Rome, University of Pavia, Rome, Italy.
B De MoerlooseDepartment of Pediatric Hematology/Oncology, Ghent University Hospital, Ghent, Belgium.
G GöhringInstitute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.
M SchmuggeDepartment of Hematology, University Children's Hospital, Zurich, Switzerland.
J StaryDepartment of Pediatric Hematology/Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
M ZeccaPediatric Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
A W LangerakDepartment of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
J J M van DongenDepartment of Immunology, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
R PietersDepartment of Pediatric Oncology/Hematology, Sophia Children's Hospital-Erasmus University Medical Center, Rotterdam, The Netherlands.
C M NiemeyerDepartment of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany.
M M van den Heuvel-EibrinkDepartment of Pediatric Oncology/Hematology, Sophia Children's Hospital-Erasmus University Medical Center, Rotterdam, The Netherlands.
Erasmus MC · NLUniversity of Freiburg · DEAarhus University Hospital · DKCharles University · CZGhent University Hospital · BEMedical University of Vienna · ATMedizinische Hochschule Hannover · DEPoliclinico San Matteo Fondazione · ITUniversity Children's Hospital Zurich · CHUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentChildChild, PreschoolFemaleHemoglobinuria, ParoxysmalHumansInfantMalePancytopeniaProspective Studies

Identifiers

PMID23807769
OpenAlexW1999082722

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.